Clinical Trial Results: A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating TransCon CNP versus placebo in children with achondroplasia has completed Phase 2/3 with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• TransCon CNP (C-type natriuretic peptide prodrug)

Snippet

Sponsor: Ascendis Pharma Growth Disorders A/S | Conditions: Achondroplasia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-07-14